TY - JOUR
T1 - Intelligent drug-delivery devices based on micro-and nano-technologies
AU - Chi, A. H.
AU - Clayton, K.
AU - Burrow, T. J.
AU - Lewis, R.
AU - Luciano, D.
AU - Alexis, F.
AU - D'Hers, S.
AU - Elman, N. M.
PY - 2013/1
Y1 - 2013/1
N2 - This review focuses on the current drug-delivery modalities in R&D, as well as commercially available. Intelligent drug-delivery systems are described as novel technological innovations and clinical approaches to improve conventional treatments. These systems differ in methodology of therapeutic administration, intricacy, materials and patient compliance to address numerous clinical conditions that require various pharmacological therapies. These systems have been primarily described as active and passive microelectrical mechanical system devices, injectors and nanoparticle-based therapies, optimized to tailor specific pharmacokinetic profiles. The most critical considerations for the design of these intelligent delivery systems include the controlled release, target specificity, on-demand dosage adjustment, mass transfer and stability of the pharmacological agents. Drug-delivery systems continue to be developed and enhanced to provide better and more sophisticated treatments, promising an improvement in quality of life and extension of life expectancy.
AB - This review focuses on the current drug-delivery modalities in R&D, as well as commercially available. Intelligent drug-delivery systems are described as novel technological innovations and clinical approaches to improve conventional treatments. These systems differ in methodology of therapeutic administration, intricacy, materials and patient compliance to address numerous clinical conditions that require various pharmacological therapies. These systems have been primarily described as active and passive microelectrical mechanical system devices, injectors and nanoparticle-based therapies, optimized to tailor specific pharmacokinetic profiles. The most critical considerations for the design of these intelligent delivery systems include the controlled release, target specificity, on-demand dosage adjustment, mass transfer and stability of the pharmacological agents. Drug-delivery systems continue to be developed and enhanced to provide better and more sophisticated treatments, promising an improvement in quality of life and extension of life expectancy.
UR - http://www.scopus.com/inward/record.url?scp=84871538148&partnerID=8YFLogxK
U2 - 10.4155/tde.12.139
DO - 10.4155/tde.12.139
M3 - Artículo de revisión
C2 - 23323782
AN - SCOPUS:84871538148
SN - 2041-5990
VL - 4
SP - 77
EP - 94
JO - Therapeutic Delivery
JF - Therapeutic Delivery
IS - 1
ER -